Tempest Therapeutics, Inc. (TPST) — SC 13D/A Filings
All SC 13D/A filings from Tempest Therapeutics, Inc.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
Versant Venture Capital VI Amends Tempest Therapeutics Stake
— Aug 12, 2024 Risk: medium
Versant Venture Capital VI, L.P. filed an amendment to its Schedule 13D on August 12, 2024, regarding its beneficial ownership of Tempest Therapeutics, Inc. The -
Versant Venture Capital VI Amends Stake in Tempest Therapeutics
— May 13, 2024 Risk: medium
Versant Venture Capital VI, L.P. and its affiliates have filed an SC 13D/A amendment on May 13, 2024, related to their holdings in Tempest Therapeutics, Inc. Th -
Versant Amends Tempest Therapeutics Stake, Signals Ownership Change
— Feb 8, 2024 Risk: medium
Versant Venture Capital VI, L.P. and its affiliated entities filed an Amendment No. 2 to their Schedule 13D, indicating a change in their beneficial ownership o
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX